Communication Dans Un Congrès Année : 2021

Preclinical pharmacokinetics and dosimetry of an [89Zr] labelled anti-PDL1 in an orthotopic lung cancer murine model.

Fichier non déposé

Dates et versions

hal-04959115 , version 1 (20-02-2025)

Identifiants

  • HAL Id : hal-04959115 , version 1

Citer

Anis Krache, Charlotte Fontan, Yann Bouvet, Pierre Payoux, Étienne Chatelut, et al.. Preclinical pharmacokinetics and dosimetry of an [89Zr] labelled anti-PDL1 in an orthotopic lung cancer murine model.. Combination in Cancer immunotherapy and Overcoming Resistance, from molecular aspects to clinical issues, 2021, Toulouse, France. ⟨hal-04959115⟩
21 Consultations
0 Téléchargements

Partager

  • More